SPX3,831.39+6.06 0.16%
DIA309.71-1.14 -0.37%
IXIC11,322.24+194.39 1.75%

BRIEF-BioCryst Selects Pint Pharma As Commercial Partner For Orladeyo Berotralstat In Latin America

reuters.com · 06/09/2022 07:38
BRIEF-BioCryst Selects Pint Pharma As Commercial Partner For Orladeyo Berotralstat In Latin America

- BioCryst Pharmaceuticals Inc BCRX:

  • BIOCRYST SELECTS PINT PHARMA AS COMMERCIAL PARTNER FOR ORLADEYO® (BEROTRALSTAT) IN LATIN AMERICA

  • BIOCRYST - PINT PHARMA WILL BE RESPONSIBLE FOR OBTAINING, MAINTAINING ALL MARKETING AUTHORIZATIONS, FOR COMMERCIALIZING ORLADEYO IN PAN-LATAM REGION

Source text for Eikon: ID:nGNX4GZmLn

Further company coverage: BCRX


((Reuters.Briefs@thomsonreuters.com;))